STOCK TITAN
  1. Home
  2. News
  3. GEHC

GE HealthCare Technologies Inc. - GEHC STOCK NEWS

Welcome to our dedicated page for GE HealthCare Technologies news (Ticker: GEHC), a resource for investors and traders seeking the latest updates and insights on GE HealthCare Technologies stock.

GE HealthCare Technologies Inc. (NYSE: GEHC) is a leading global innovator in medical technology, pharmaceutical diagnostics, and digital solutions. The company operates through four main segments: Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Of these, the Imaging segment generates the majority of the company’s revenue.

GE HealthCare is dedicated to providing transformational medical technologies and services that enhance access to quality, affordable healthcare worldwide. Through its cutting-edge products and comprehensive solutions, the company aims to improve patient outcomes and streamline healthcare delivery.

Recent achievements include advancements in artificial intelligence (AI) integration within medical imaging, which supports more accurate and efficient diagnostics. The company is also involved in numerous partnerships with healthcare providers and research institutions to drive innovation and improve global healthcare standards.

Financially, GE HealthCare has showcased robust performance, with steady revenue growth and strong market presence. The company continuously invests in R&D to maintain its edge in the competitive healthcare industry. Their suite of products includes advanced imaging machines, ultrasound devices, patient monitoring systems, and contrast media for diagnostic imaging.

As part of a highly regulated industry, GE HealthCare adheres to strict compliance standards and maintains rigorous quality controls across its operations. The company actively engages with its community, although it reserves the right to monitor and manage public interactions to uphold professional and constructive discourse.

News

GE HealthCare Introduces Vscan Air SL, a Wireless Handheld Ultrasound Device for Rapid Assessments of Cardiac and Vascular Patients

Rhea-AI Summary
GE HealthCare launches Vscan Air SL, a handheld wireless ultrasound imaging system for cardiac and vascular assessments at the point of care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.23%
Tags
none
-
News

GE HealthCare Launches CardioVisio for Atrial Fibrillation, a Digital, Patient-Centric Clinical Decision Support Tool to Enable Precision Care

Rhea-AI Summary
GE HealthCare launches CardioVisio for Atrial Fibrillation, a digital tool to assist clinicians in visualizing longitudinal data and providing evidence-based clinical decision support.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.81%
Tags
none
-
News

GE HealthCare Management to Present at September Investor Conferences

Rhea-AI Summary
GE HealthCare senior management team to present at investor conferences next month.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.81%
Tags
conferences
News

Genpact to Streamline US Leasing and Lending Operations for GE HealthCare with AI-Powered Platform Genpact Cora

Rhea-AI Summary
Genpact partners with GE Healthcare to enhance financing capabilities for customers acquiring medical equipment through loans and leases.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.09%
Tags
AI
-
News

GE HealthCare Receives FDA Clearance for Portrait Mobile, A First-Of-Its-Kind, Wireless Monitoring Solution Aiding Early Detection of Patient Deterioration

Rhea-AI Summary
GE HealthCare has received FDA clearance for its Portrait Mobile wireless and wearable monitoring solution. The device allows for continuous monitoring of vital signs, such as respiration rate, SpO2, and pulse rate, while keeping patients mobile. This technology can help clinicians detect patient deterioration earlier than traditional methods.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.29%
Tags
clinical trial
-
News

GE HealthCare Reports Second Quarter 2023 Financial Results

Rhea-AI Summary
GE HealthCare reports 2Q revenue growth of 7% YoY, with organic revenue growth of 9%. Net income attributable to GE HealthCare was $418M, and adjusted EBIT was $711M. Diluted EPS was $0.91, and adjusted EPS was $0.92. Raises full-year guidance for organic revenue growth and adjusted EPS.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.52%
Tags
earnings
News

GE HealthCare to Announce Second Quarter 2023 Results on July 25, 2023

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.93%
Tags
earnings
-
News

From General to Personalized Care: GE HealthCare is Focused on Disease Detection and More Holistic and Effective Treatment Options

Rhea-AI Summary
GE HealthCare will showcase new technologies and diagnostics at the SNMMI23 annual meeting to enable personalized medicine and precision care. This includes AI solutions for enhanced image quality, advancements in Theranostics, and milestones in pharmaceutical diagnostics. GE HealthCare aims to provide clinicians with innovative tools to improve patient outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News

GE HealthCare Announces Cash Dividend for Second Quarter of Fiscal Year 2023

Rhea-AI Summary
GE HealthCare Technologies Inc. (Nasdaq: GEHC) has announced a cash dividend of $0.03 per share of Common Stock for the second quarter of 2023. The dividend will be payable on August 15, 2023, to shareholders of record as of July 21, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.49%
Tags
dividends earnings
News

GE HealthCare Advances PET/MR Capabilities with AIR Technologies

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.49%
Tags
none

FAQ

What is the current stock price of GE HealthCare Technologies (GEHC)?

The current stock price of GE HealthCare Technologies (GEHC) is $79.36 as of December 24, 2024.

What is the market cap of GE HealthCare Technologies (GEHC)?

The market cap of GE HealthCare Technologies (GEHC) is approximately 36.3B.

What does GE HealthCare Technologies Inc. do?

GE HealthCare Technologies Inc. provides transformative medical technologies, pharmaceutical diagnostics, and digital solutions to improve healthcare access and quality globally.

What are the main business segments of GE HealthCare?

The main business segments are Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).

How does GE HealthCare generate most of its revenue?

The company generates the majority of its revenue from the Imaging segment.

What recent advancements has GE HealthCare made?

GE HealthCare has made significant advancements in AI integration within medical imaging, improving diagnostic accuracy and efficiency.

Who are GE HealthCare's partners?

The company collaborates with healthcare providers and research institutions to drive innovation and improve healthcare standards.

How does GE HealthCare ensure compliance?

GE HealthCare adheres to strict regulatory compliance standards and maintains rigorous quality controls across its operations.

What products does GE HealthCare offer?

GE HealthCare offers a range of products, including imaging machines, ultrasound devices, patient monitoring systems, and diagnostic contrast media.

What is GE HealthCare's commitment to the community?

The company engages actively with its community and strives to maintain professional and positive interactions while monitoring public posts and conversations.

How has GE HealthCare performed financially?

GE HealthCare has shown robust financial performance with steady revenue growth, supported by continuous investment in research and development.

What is GE HealthCare's mission?

GE HealthCare is committed to improving patient outcomes and making quality healthcare more accessible and affordable worldwide.

Stock GEHC logo
GE HealthCare Technologies Inc.

Nasdaq:GEHC

GEHC Rankings

#356 Ranked by Market Cap
#2115 Ranked by Dividends

GEHC Stock Data

36.26B
442.78M
3.09%
83.53%
1.91%
Health Information Services
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States of America
CHICAGO